MRFRの分析によると、局所ドラッグデリバリーの市場規模は2022年に32.54 (10億ドル)と推定されました。この市場は、2023年の34.67 (10億 ドル) から2032年までに61.4 (10億ドル) に成長し、予測期間中 (2024-2032) のCAGRは約6.55%になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. TOPICAL DRUG DELIVERY MARKET, BY FORMULATION TYPE (USD BILLION)
6.1. Creams
6.2. Gels
6.3. Ointments
6.4. Lotions
6.5. Patches
7. TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Transdermal
7.2. Topical
7.3. Localized
8. TOPICAL DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION (USD BILLION)
8.1. Dermatology
8.2. Pain Management
8.3. Infection Control
8.4. Cosmetic Enhancements
9. TOPICAL DRUG DELIVERY MARKET, BY DOSAGE FORM (USD BILLION)
9.1. Single-Dose
9.2. Multi-Dose
10. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
10.1. Hospital Pharmacies
10.2. Retail Pharmacies
10.3. E-commerce
10.4. Clinics
11. TOPICAL DRUG DELIVERY MARKET, BY REGIONAL (USD BILLION)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. UK
11.2.3. France
11.2.4. Russia
11.2.5. Italy
11.2.6. Spain
11.2.7. Rest of Europe
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Malaysia
11.3.6. Thailand
11.3.7. Indonesia
11.3.8. Rest of APAC
11.4. South America
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of South America
11.5. MEA
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of MEA
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market share Analysis
12.4. Major Growth Strategy in the Topical Drug Delivery Market
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Topical Drug Delivery Market
12.7. Key developments and growth strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales and Operating Income
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. Mylan N.V.
13.1.1. Financial Overview
13.1.2. Products Offered
13.1.3. Key Developments
13.1.4. SWOT Analysis
13.1.5. Key Strategies
13.2. Dermira Inc.
13.2.1. Financial Overview
13.2.2. Products Offered
13.2.3. Key Developments
13.2.4. SWOT Analysis
13.2.5. Key Strategies
13.3. Pfizer Inc.
13.3.1. Financial Overview
13.3.2. Products Offered
13.3.3. Key Developments
13.3.4. SWOT Analysis
13.3.5. Key Strategies
13.4. AbbVie Inc.
13.4.1. Financial Overview
13.4.2. Products Offered
13.4.3. Key Developments
13.4.4. SWOT Analysis
13.4.5. Key Strategies
13.5. Medtronic plc
13.5.1. Financial Overview
13.5.2. Products Offered
13.5.3. Key Developments
13.5.4. SWOT Analysis
13.5.5. Key Strategies
13.6. Heraeus Holding GmbH
13.6.1. Financial Overview
13.6.2. Products Offered
13.6.3. Key Developments
13.6.4. SWOT Analysis
13.6.5. Key Strategies
13.7. Novartis AG
13.7.1. Financial Overview
13.7.2. Products Offered
13.7.3. Key Developments
13.7.4. SWOT Analysis
13.7.5. Key Strategies
13.8. Bayer AG
13.8.1. Financial Overview
13.8.2. Products Offered
13.8.3. Key Developments
13.8.4. SWOT Analysis
13.8.5. Key Strategies
13.9. Johnson Johnson
13.9.1. Financial Overview
13.9.2. Products Offered
13.9.3. Key Developments
13.9.4. SWOT Analysis
13.9.5. Key Strategies
13.10. Boehringer Ingelheim
13.10.1. Financial Overview
13.10.2. Products Offered
13.10.3. Key Developments
13.10.4. SWOT Analysis
13.10.5. Key Strategies
13.11. Sientra Inc.
13.11.1. Financial Overview
13.11.2. Products Offered
13.11.3. Key Developments
13.11.4. SWOT Analysis
13.11.5. Key Strategies
13.12. Galderma S.A.
13.12.1. Financial Overview
13.12.2. Products Offered
13.12.3. Key Developments
13.12.4. SWOT Analysis
13.12.5. Key Strategies
13.13. GlaxoSmithKline plc
13.13.1. Financial Overview
13.13.2. Products Offered
13.13.3. Key Developments
13.13.4. SWOT Analysis
13.13.5. Key Strategies
13.14. Teva Pharmaceutical Industries Ltd.
13.14.1. Financial Overview
13.14.2. Products Offered
13.14.3. Key Developments
13.14.4. SWOT Analysis
13.14.5. Key Strategies
13.15. AstraZeneca plc
13.15.1. Financial Overview
13.15.2. Products Offered
13.15.3. Key Developments
13.15.4. SWOT Analysis
13.15.5. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 7. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 8. US TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 9. US TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 10. US TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 11. US TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 12. US TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 13. US TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 17. CANADA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 18. CANADA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 19. CANADA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 22. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 23. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 24. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 25. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 27. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 28. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 29. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 30. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 31. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. UK TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. UK TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 34. UK TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 35. UK TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 36. UK TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 37. UK TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 40. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 41. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 42. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 43. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 44. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 45. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 46. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 47. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 48. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 49. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. ITALY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. ITALY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 52. ITALY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 53. ITALY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 54. ITALY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 55. ITALY TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 56. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 57. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 58. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 59. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 60. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 61. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 64. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 65. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 66. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 67. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 68. APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 69. APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 70. APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 71. APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 72. APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 73. APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. CHINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. CHINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 76. CHINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 77. CHINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 78. CHINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 79. CHINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 80. INDIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 81. INDIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 82. INDIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 83. INDIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 84. INDIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 85. INDIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 87. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 88. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 89. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 90. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 91. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 94. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 95. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 96. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 97. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 100. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 101. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 102. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 103. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 104. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 105. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 106. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 107. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 108. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 109. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 112. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 113. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 114. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 115. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 118. REST OF APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 119. REST OF APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 120. REST OF APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 121. REST OF APAC TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 124. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 125. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 126. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 127. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 128. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 129. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 130. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 131. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 132. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 133. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 134. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 135. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 136. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 137. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 138. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 139. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 140. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 141. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 142. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 143. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 144. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 145. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 147. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 148. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 149. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 150. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 151. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 152. MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 153. MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 154. MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 155. MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 156. MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 157. MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 158. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 159. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 160. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 161. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 162. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 163. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 164. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 165. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 166. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 167. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 168. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 169. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 170. REST OF MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD BILLIONS)
TABLE 171. REST OF MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 172. REST OF MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 173. REST OF MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 174. REST OF MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 175. REST OF MEA TOPICAL DRUG DELIVERY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 176. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 177. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS
FIGURE 3. US TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 4. US TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 5. US TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 6. US TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 7. US TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 8. US TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 9. CANADA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 10. CANADA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 11. CANADA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 12. CANADA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 13. CANADA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 14. CANADA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 15. EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS
FIGURE 16. GERMANY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 17. GERMANY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 18. GERMANY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 19. GERMANY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 20. GERMANY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 21. GERMANY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 22. UK TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 23. UK TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 24. UK TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 25. UK TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 26. UK TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 27. UK TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 28. FRANCE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 29. FRANCE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 30. FRANCE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 31. FRANCE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 32. FRANCE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 33. FRANCE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 34. RUSSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 35. RUSSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 36. RUSSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 37. RUSSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 38. RUSSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 39. RUSSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 40. ITALY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 41. ITALY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 42. ITALY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 43. ITALY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 44. ITALY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 45. ITALY TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 46. SPAIN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 47. SPAIN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 48. SPAIN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 49. SPAIN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 50. SPAIN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 51. SPAIN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 52. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 53. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 54. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 55. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 56. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 57. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 58. APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS
FIGURE 59. CHINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 60. CHINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 61. CHINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 62. CHINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 63. CHINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 64. CHINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 66. INDIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 67. INDIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 68. INDIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 69. INDIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 70. INDIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 71. JAPAN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 72. JAPAN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 73. JAPAN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 74. JAPAN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 75. JAPAN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 76. JAPAN TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 77. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 78. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 79. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 80. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 81. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 82. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 83. MALAYSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 84. MALAYSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 85. MALAYSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 86. MALAYSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 87. MALAYSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 88. MALAYSIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 89. THAILAND TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 90. THAILAND TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 91. THAILAND TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 92. THAILAND TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 93. THAILAND TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 94. THAILAND TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 95. INDONESIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 96. INDONESIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 97. INDONESIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 98. INDONESIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 99. INDONESIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 100. INDONESIA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 101. REST OF APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 102. REST OF APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 103. REST OF APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 104. REST OF APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 105. REST OF APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 106. REST OF APAC TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 107. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS
FIGURE 108. BRAZIL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 109. BRAZIL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 110. BRAZIL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 111. BRAZIL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 112. BRAZIL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 113. BRAZIL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 114. MEXICO TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 115. MEXICO TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 116. MEXICO TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 117. MEXICO TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 118. MEXICO TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 119. MEXICO TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 120. ARGENTINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 121. ARGENTINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 122. ARGENTINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 123. ARGENTINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 124. ARGENTINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 125. ARGENTINA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 126. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 127. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 128. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 129. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 130. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 131. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 132. MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS
FIGURE 133. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 134. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 135. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 136. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 137. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 138. GCC COUNTRIES TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 139. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 140. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 141. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 142. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 143. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 144. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 145. REST OF MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY FORMULATION TYPE
FIGURE 146. REST OF MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 147. REST OF MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
FIGURE 148. REST OF MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DOSAGE FORM
FIGURE 149. REST OF MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 150. REST OF MEA TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGIONAL
FIGURE 151. KEY BUYING CRITERIA OF TOPICAL DRUG DELIVERY MARKET
FIGURE 152. RESEARCH PROCESS OF MRFR
FIGURE 153. DRO ANALYSIS OF TOPICAL DRUG DELIVERY MARKET
FIGURE 154. DRIVERS IMPACT ANALYSIS: TOPICAL DRUG DELIVERY MARKET
FIGURE 155. RESTRAINTS IMPACT ANALYSIS: TOPICAL DRUG DELIVERY MARKET
FIGURE 156. SUPPLY / VALUE CHAIN: TOPICAL DRUG DELIVERY MARKET
FIGURE 157. TOPICAL DRUG DELIVERY MARKET, BY FORMULATION TYPE, 2024 (% SHARE)
FIGURE 158. TOPICAL DRUG DELIVERY MARKET, BY FORMULATION TYPE, 2019 TO 2032 (USD Billions)
FIGURE 159. TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 160. TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 161. TOPICAL DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
FIGURE 162. TOPICAL DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 163. TOPICAL DRUG DELIVERY MARKET, BY DOSAGE FORM, 2024 (% SHARE)
FIGURE 164. TOPICAL DRUG DELIVERY MARKET, BY DOSAGE FORM, 2019 TO 2032 (USD Billions)
FIGURE 165. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
FIGURE 166. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2032 (USD Billions)
FIGURE 167. TOPICAL DRUG DELIVERY MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 168. TOPICAL DRUG DELIVERY MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 169. BENCHMARKING OF MAJOR COMPETITORS
